We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Confirms Patentability Of Epilepsy Treatment

Mealey's (February 4, 2019, 11:04 AM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on Feb. 1 rejected a challenge to an adverse inter partes review (IPR) by the Patent Trial and Appeal Board, agreeing...
To view the full article, register now.